CN103328487B - 作为pde10a酶抑制剂的咪唑衍生物 - Google Patents

作为pde10a酶抑制剂的咪唑衍生物 Download PDF

Info

Publication number
CN103328487B
CN103328487B CN201180065325.2A CN201180065325A CN103328487B CN 103328487 B CN103328487 B CN 103328487B CN 201180065325 A CN201180065325 A CN 201180065325A CN 103328487 B CN103328487 B CN 103328487B
Authority
CN
China
Prior art keywords
triazolo
imidazo
compound
dimethyl
isoindole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201180065325.2A
Other languages
English (en)
Chinese (zh)
Other versions
CN103328487A (zh
Inventor
J.科勒
J.尼伊森
M.马里戈
J.P.基尔布恩
M.兰格尔德
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of CN103328487A publication Critical patent/CN103328487A/zh
Application granted granted Critical
Publication of CN103328487B publication Critical patent/CN103328487B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CN201180065325.2A 2010-11-19 2011-11-18 作为pde10a酶抑制剂的咪唑衍生物 Expired - Fee Related CN103328487B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201001045 2010-11-19
DKPA201001045 2010-11-19
PCT/DK2011/000136 WO2012065612A1 (en) 2010-11-19 2011-11-18 Imidazole derivatives as pde10a enzyme inhibitors

Publications (2)

Publication Number Publication Date
CN103328487A CN103328487A (zh) 2013-09-25
CN103328487B true CN103328487B (zh) 2015-11-25

Family

ID=45217102

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180065325.2A Expired - Fee Related CN103328487B (zh) 2010-11-19 2011-11-18 作为pde10a酶抑制剂的咪唑衍生物

Country Status (32)

Country Link
EP (1) EP2640731B9 (https=)
JP (1) JP5937608B2 (https=)
KR (1) KR101916487B1 (https=)
CN (1) CN103328487B (https=)
AP (1) AP3342A (https=)
AR (1) AR083926A1 (https=)
AU (1) AU2011331607B2 (https=)
BR (1) BR112013012378A2 (https=)
CA (1) CA2817663C (https=)
CR (1) CR20130226A (https=)
DK (1) DK2640731T3 (https=)
EA (1) EA027082B1 (https=)
EC (1) ECSP13012698A (https=)
ES (1) ES2547090T3 (https=)
GE (1) GEP20156346B (https=)
GT (1) GT201300130A (https=)
HU (1) HUE025596T2 (https=)
JO (1) JO3089B1 (https=)
ME (1) ME02193B (https=)
MY (1) MY163327A (https=)
NZ (1) NZ610353A (https=)
PE (1) PE20141534A1 (https=)
PH (1) PH12013500968A1 (https=)
PL (1) PL2640731T3 (https=)
PT (1) PT2640731E (https=)
RS (1) RS54210B1 (https=)
SG (1) SG190282A1 (https=)
SI (1) SI2640731T1 (https=)
TW (1) TWI541245B (https=)
UA (1) UA112065C2 (https=)
WO (1) WO2012065612A1 (https=)
ZA (1) ZA201303607B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8552045B2 (en) 2010-11-19 2013-10-08 H. Lundbeck A/S Tricyclic imidazole compounds as PDE10 inhibitors
CN107141309A (zh) 2011-01-11 2017-09-08 桑诺维恩药品公司 杂芳基化合物及其使用方法
WO2013045607A1 (en) * 2011-09-30 2013-04-04 H. Lundbeck A/S Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors
WO2013107856A1 (en) * 2012-01-20 2013-07-25 H. Lundbeck A/S Imidazole derivatives as pde10a enzyme inhibitors
RU2644558C2 (ru) * 2012-06-19 2018-02-13 Сановьон Фармасьютикалз Инк. Гетероарильные соединения и способы их применения
CN103435617B (zh) * 2013-08-22 2016-04-27 南京华安药业有限公司 一种6,7-二氢-5H-吡咯并[1,2-a]咪唑-2-甲醛的合成方法
JO3627B1 (ar) 2015-04-30 2020-08-27 H Lundbeck As إيميدازو بيرازينونات على هيئة مثبطات pde1
TWI729109B (zh) 2016-04-12 2021-06-01 丹麥商Ｈ 朗德貝克公司 作爲PDE1抑制劑的1,5-二氫-4H-吡唑并[3,4-d]嘧啶-4-酮和1,5-二氫-4H-吡唑并[4,3-c]吡啶-4-酮
ES2967489T3 (es) 2016-10-18 2024-04-30 H Lundbeck As Imidazopirazinonas, pirazolopirimidinonas y pirazolopiridinonas como inhibidores de PDE1
MX2019004859A (es) 2016-10-28 2019-06-20 H Lundbeck As Tratamientos de combinacion que comprenden la administracion de imidazopirazinonas.
RU2019109039A (ru) 2016-10-28 2020-11-30 Х. Лундбекк А/С Комбинированные средства для лечения, предусматривающего введение имидазопиразинонов, предназначенные для лечения психических и/или когнитивных расстройств
BR112020013820A2 (pt) 2018-11-06 2021-06-01 H. Lundbeck A/S inibidores de pde10a para tratamento de sintomas negativos e comprometimentos cognitivos em um paciente sofrendo de esquizofrenia
CN109776527A (zh) * 2019-02-21 2019-05-21 药雅科技(上海)有限公司 一种5-溴-7-氮杂吲哚的合成方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152825A1 (en) * 2008-06-20 2009-12-23 H. Lundbeck A/S Novel phenylimidazole derivatives as pde10a enzyme inhibitors
WO2010145668A1 (en) * 2009-06-19 2010-12-23 H. Lundbeck A/S Novel phenylimidazole derivative as pde10a enzyme inhibitor
WO2011072694A1 (en) * 2009-12-17 2011-06-23 H. Lundbeck A/S Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
WO2011072695A1 (en) * 2009-12-17 2011-06-23 H. Lundbeck A/S Phenylimidazole derivatives comprising an ethynylene linker as pde10a enzyme inhibitors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8307865D0 (en) 1983-03-22 1983-04-27 Fujisawa Pharmaceutical Co Benzimidazole derivatives
US5571775A (en) 1994-07-11 1996-11-05 Dowelanco N-aryl[1,2,4]triazolo[1,5-a]pyridine-2-sulfonamide herbicides
US20030032579A1 (en) 2001-04-20 2003-02-13 Pfizer Inc. Therapeutic use of selective PDE10 inhibitors
IL149106A0 (en) 2001-04-20 2002-11-10 Pfizer Prod Inc Therapeutic use of selective pde10 inhibitors
RS20050945A (sr) 2003-06-30 2008-06-05 Altana Pharma Ag., Novi pirolodihidroizohinolini koji se mogu upotrebiti u tretmanu kancera
ES2331519T3 (es) 2003-06-30 2010-01-07 Nycomed Gmbh Derivados de pirrolo-dihidroisoquinolina como inhibidores de pde10.
EP1651251A4 (en) 2003-07-31 2008-06-18 Bayer Pharmaceuticals Corp METHOD FOR THE TREATMENT OF DIABETES AND RELATED DISEASES USING PDE 10A INHIBITORS
JP2007523152A (ja) 2004-02-18 2007-08-16 ファイザー・プロダクツ・インク キナゾリンおよびイソキノリンのテトラヒドロイソキノリニル誘導体
WO2005120514A1 (en) 2004-06-07 2005-12-22 Pfizer Products Inc. Phosphodiesterase 10 inhibition as treatment for obesity-related and metabolic syndrome-related conditions
US20060019975A1 (en) 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
AU2005282721A1 (en) 2004-09-03 2006-03-16 Memory Pharmaceuticals Corporation 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
US8133897B2 (en) * 2008-06-20 2012-03-13 H. Lundbeck A/S Phenylimidazole derivatives as PDE10A enzyme inhibitors
TWI481607B (zh) * 2009-12-17 2015-04-21 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑的２－芳基咪唑衍生物

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009152825A1 (en) * 2008-06-20 2009-12-23 H. Lundbeck A/S Novel phenylimidazole derivatives as pde10a enzyme inhibitors
WO2010145668A1 (en) * 2009-06-19 2010-12-23 H. Lundbeck A/S Novel phenylimidazole derivative as pde10a enzyme inhibitor
WO2011072694A1 (en) * 2009-12-17 2011-06-23 H. Lundbeck A/S Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors
WO2011072695A1 (en) * 2009-12-17 2011-06-23 H. Lundbeck A/S Phenylimidazole derivatives comprising an ethynylene linker as pde10a enzyme inhibitors

Also Published As

Publication number Publication date
ME02193B (me) 2016-02-20
ZA201303607B (en) 2014-07-30
JP2013542963A (ja) 2013-11-28
EA027082B1 (ru) 2017-06-30
CA2817663A1 (en) 2012-05-24
PL2640731T3 (pl) 2015-11-30
JO3089B1 (ar) 2017-03-15
SG190282A1 (en) 2013-06-28
EP2640731A1 (en) 2013-09-25
GT201300130A (es) 2015-01-16
EP2640731B9 (en) 2015-11-25
UA112065C2 (uk) 2016-07-25
CR20130226A (es) 2013-09-03
KR101916487B1 (ko) 2018-11-07
SI2640731T1 (sl) 2015-10-30
GEP20156346B (en) 2015-08-10
CN103328487A (zh) 2013-09-25
AU2011331607A1 (en) 2013-05-30
AR083926A1 (es) 2013-04-10
JP5937608B2 (ja) 2016-06-22
AP3342A (en) 2015-07-31
ES2547090T3 (es) 2015-10-01
WO2012065612A1 (en) 2012-05-24
CA2817663C (en) 2020-04-28
MY163327A (en) 2017-09-15
PH12013500968A1 (en) 2022-10-24
AU2011331607B2 (en) 2016-05-19
RS54210B1 (sr) 2015-12-31
AP2013006928A0 (en) 2013-06-30
TW201300391A (zh) 2013-01-01
HUE025596T2 (en) 2016-03-29
TWI541245B (zh) 2016-07-11
KR20140009192A (ko) 2014-01-22
PE20141534A1 (es) 2014-11-16
PT2640731E (pt) 2015-10-13
ECSP13012698A (es) 2013-08-30
DK2640731T3 (en) 2015-08-31
NZ610353A (en) 2015-01-30
BR112013012378A2 (pt) 2016-08-30
EP2640731B1 (en) 2015-07-08
EA201390741A1 (ru) 2013-11-29

Similar Documents

Publication Publication Date Title
CN103328487B (zh) 作为pde10a酶抑制剂的咪唑衍生物
CN102124002B (zh) 作为pde10a酶抑制剂的新颖苯基咪唑衍生物
CA2783727C (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
CN102741250B (zh) 作为pde10a酶抑制剂的杂芳族苯基咪唑衍生物
CA2783728C (en) Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
US9062060B2 (en) Substituted imidazo[2,1-A]isoindoles as PDE10 inhibitors
HK1189593B (en) Imidazole derivatives as pde10a enzyme inhibitors
MX2013005592A (es) Derivados de imidazol como inhibidores de la enzima pde10a.
OA16430A (en) Imidazole derivatives as PDE10A ensyme inhibitors
WO2013045607A1 (en) Quinazoline linked heteroaromatic tricycle derivatives as pde10a enzyme inhibitors
HK1177208B (en) Heteroaromatic phenylimidazole derivatives as pde10a enzyme inhibitors

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20151125

Termination date: 20211118